Original Article

Design, Expression and Purification of Strongyloides stercoralis IgG4 Immunoreactive Protein (NIE) in Escherichia coli


Background: Strongyloidiasis is a public health concern in northern regions of Iran, caused by Strongyloides stercoralis. Auto-infection cycle can be resulted in high parasitic load, especially in immunocompromised hosts. Because of low sensitivity of stool culture and stool-based microscopy techniques, detection of antibodies in patient’s sera can be an alternative diagnostic technique for detection of the nematode. In the present study, as the first step of the development of an ELISA kit for the detection of antibodies against the nematode, IgG4 immunoreactive protein (NIE) was expressed in Escherichia coli expression system, purified and verified.

Methods: The NIE gene sequence was retrieved from the GenBank. This sequence was codon-optimized for the expression in E. coli BL21 (DE3). The sequence was inserted into the expression vector pET-30b (+). The recombinant vector was then transferred into competent E. coli BL21 (DE3). Transformed colonies were selected and verified by colony PCR. NIE gene expression was induced with IPTG induction. The protein production was evaluated by SDS-PAGE and verified using Western blotting.

Results: The codon-optimized NIE gene had required parameters for expression in E. coli. NIE protein was proved and verified by SDS-PAGE and Western blotting. 

Conclusion: NIE recombinant protein was successfully expressed in E. coli expression system in appropriate amounts. The recombinant protein can be used for developing ELISA kit in diagnosis of S. stercoralis.

1. Jourdan PM, Lamberton PHL, Fenwick PA, et al. Soil-transmitted helminth infections. The Lancet. 2018; 391(10117):252-65.
2. Pagheh AS, Sharif M, Daryani A, et al. A cross-sectional analysis of intestinal parasitic infections among the general population in north of Iran. J Infect Dev Ctries, 2018; 12(2):120-6.
3. Jafari R, Fallah M, Yousofi-Darani H, et al. Prevalence of intestinal parasitic infections among rural inhabitants of Hamadan city, Iran, 2012. Avicenna J Clin Microbiol Infect. 2014; 1(2).
4. Asmar M, Ashrafi K, Amintahmasbi H, et al. Prevalence of Intestinal Parasitic Infections in the Urban Areas of Bandar Anzali, Northern Iran. Gui-lan University of Medical Sciences. 2014; 22(88):18-25.
5. Saeidinia A, Tavakoli I, Naghipour MA, et al. Prevalence of Strongyloides stercoralis and other intestinal parasites among institutionalized mentally disabled individuals in Rasht, northern Iran. Iran J Parasitol. 2016; 11(4):527-533.
6. Toledo R, Munoz-Antoli C, Esteban JG. Strongyloidiasis with emphasis on human infections and its different clinical forms. Adv Parasitol. 2015; 88:165-241.
7. Keiser PB, and TB Nutman. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004; 17(1):208-17.
8. Naves MM, Costa-Cruz JM. High prevalence of Strongyloides stercoralis infection among the elderly in Brazil. Revista do Instituto de Medicina Tropical de São Paulo. 2013; 55(5):309-13.
9. Anderson NW, Kelvin DM, Dormik SM, et al. Comparison of three immunoassays for detection of antibodies to Strongyloides stercoralis. Clin Vaccine Immunol. 2014; 21(5):732-6.
10. Maraha B, Buiting AGM, Hol C, et al. The risk of Strongyloides stercoralis transmission from patients with disseminated strongyloidiasis to the medical staff. J Hosp Infect. 2001; 49(3):222-4.
11. Ramanathan R, Burbelo PD, Groot S, et al. A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis. 2008; 198(3):444-51.
12. Rascoe LN, Price C, Shin SH, et al. Development of Ss-NIE-1 recombinant antigen based assays for immunodiagnosis of strongyloidiasis. PLoS Negl Trop Dis. 2015; 9(4):e0003694.
13. Mounsey K., Kearns T, Rampton M, et al. Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE. Acta Trop. 2014; 138:78-82.
14. Loutfy MR, Wilson M, Keystone JS, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg. 2002; 66(6):749-52.
15. Ravi V, Ramachandran S, Thompson RW, et al. Characterization of a recombinant immunodiagnostic antigen (NIE) from Strongyloides stercoralis L3-stage larvae. Mol Biochem Parasitol. 2002; 125(1-2):73-81.
16. Krolewiecki AJ, Ramanathan R, Fink V, et al. Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin Vaccine Immunol. 2010; 17(10):1624-30.
17. Pak BJ, Vasquez-Camargo F, Kalinichenko E, et al. Development of a rapid serological assay for the diagnosis of strongyloidiasis using a novel diffraction-based biosensor technology. PLoS Negl Trop Dis. 2014; 8(8):e3002.
18. Puigbo P, Guzman E, Romeu A, et al. OPTIMIZER: a web server for optimizing the codon usage of DNA sequences. Nucleic Acids Res. 2007; 35(Web Server issue):W126-W131.
19. Hamidi B, Ebrahimi F, Hajizadeh A, et al. Fusion and cloning of the binding domains of botulinum neurotoxin type A and B in E. coli DH5α. Europ J Exp Biol. 2012; 2(4):1154-60.
20. Chung CT, Miller RH. Preparation and storage of competent Escherichia coli cells.Methods Enzymol. 1993; 218:621-7.
21. Hajizade A, Salmanian AH, Amani J, et al. EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7. Artif Cells Nanomed Biotechno. 2018; 46(Sup 3):S1067-S1075.
22. Sayadmanesh A, Ebrahimi F, Hajizade A, et al. Expression and Purification of Neurotoxin-Associated Protein HA-33/A from Clostridium botulinum and Evaluation of Its Antigenicity. Iran Biomed J. 2013; 17(4):165-70.
23. Hoffmann A, Roeder R. Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies. Nucleic Acids Res. 1991; 19(22): 6337-6338.
24. Kruger NJ. The Bradford method for protein quantitation. The protein protocols handbook: 17-24. Humana Press, Totowa, NJ, 2009.
25. Hajizade A, Ebrahimi F, Amani J, et al. Design and in silico analysis of pentavalent chimeric antigen against three enteropathogenic bacteria: enterotoxigenic E . coli , enterohemorragic E. coli and Shigella. Biosci Biotech Res Comm. 2016; 9(2):225-239.
26. Welch M, Govindarajan S, Ness JE, et al. Design parameters to control synthetic gene expression in Escherichia coli. PLoS One. 2009; 4(9):e7002.
27. Tuller T, Waldman YY, Kupiec M, et al. Translation efficiency is determined by both codon bias and folding energy. Proceedings of the National Academy of Sciences. 2010; 107(8):3645-50.
28. Rodnina MV. The ribosome in action: Tuning of translational efficiency and protein folding. Protein Sci. 2016;25(8):1390-406.
29. Shirai A, Matsuyama A, Yashiroda Y, et al. Global analysis of gel mobility of proteins and its use in target identification. J Biol Chem. 2008; 283(16):10745-52.
IssueVol 15 No 3 (2020) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijpa.v15i3.4198
Strongyloides stercoralis Immunodiagnostic Protein expression

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
DASTAN K, ASSMAR M, AMIRMOZAFARI N, GHANAEI FM, MIRPOUR M. Design, Expression and Purification of Strongyloides stercoralis IgG4 Immunoreactive Protein (NIE) in Escherichia coli. Iran J Parasitol. 2020;15(3):341-348.